AI assistant
IMMUTEP LIMITED — Capital/Financing Update 2009
Aug 10, 2009
65122_rns_2009-08-10_69aaaedd-47d7-49ad-8900-c194b75d40bc.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [193 x 52] intentionally omitted <==
ASX ANNOUNCEMENT
Notice Under Section 708A(5) of the Corporations Act [ASX Code: PRR]
Tuesday, 11 August 2009
This notice is given under paragraph (5)(e) of section 708A of the Corporations Act.
The Following securities of the Company were issued under a Convertible Loan Agreement without disclosure to investors under Part 6D.2 of the Corporations Act:
| Type: | OrdinaryShares | Unlisted Options |
|---|---|---|
| Class/Description: | Ordinary (Fully Paid) | Exercisable at $0.1053 on orbefore10August 2014 |
| ASX Code: | PRR | To be announced |
| Date of Issue: | 10 August 2009 | 10 August 2009 |
| Number Issued: | 7,739,938 | 1,547,988 |
| Issue Priceper Security: | $0.0646 | Nil |
The Company intends to apply to Australian Stock Exchange Limited for quotation of the above shares.
As at the date of this notice, the Company has complied with:
a) The provisions of Chapter 2M of the Corporations Act as they apply to the Company; and b) Section 674 of the Corporations Act.
| Other information which is excludedinformation required to be disclosed underparagraph 708A (7) & 708A(8) of theCorporationsAct | None |
|---|
For and on behalf of the Company,
==> picture [139 x 42] intentionally omitted <==
Robert Kleine Company Secretary Prima Biomed Limited